Press release
Insomnia Treatment Market is thriving worldwide by 2029
Insomnia can occur due to mental stress, chronic pain, restless leg syndrome, menopause, and others. The increasing prevalence of insomnia primarily drives the growth of the market during the forecast. Some of the factors that lead to insomnia include excessive stress, eating too much late in the evening, and sleep apnea disorders. Primarily, insomnia can be treated by improving sleep hygiene and lifestyle. Sleep lifestyle may get better with consistent bedtime, a quiet and darkroom, exposure to sunlight, and regular exercise.
Further, the development of novel technologies and medical devices are also projected to propel the market growth. Medical devices such as Fisher Wallace Stimulator, Ebb Insomnia Therapy, and Alpha-Stim AID are some of the approved medical devices that are used for the treatment of insomnia. Thus, the adoption of drug and device combination therapies for treating insomnia is likely to boost the market growth over the forecast period.
To Request a Sample of our Report on Insomnia Treatment Market: https://www.omrglobal.com/request-sample/insomnia-treatment-market
Insomnia Treatment Market Segmentation
By Type
Drugs
Antidepressants
Benzodiazepine
Nonbenzodiazepine
Melatonin Receptor Agonist
Orexin Antagonist
Others
Devices
By Sales Channels
Prescription
Over-the-Counter (OTC)
A full Report of Insomnia Treatment Market is Available @ https://www.omrglobal.com/industry-reports/insomnia-treatment-market
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East and Africa
Company Profiles
Arena Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
Eisai Co. Ltd.
Electromedical Products International Inc.
Eli Lilly and Co.
GlaxoSmithKline Plc
Mallinckrodt LLC
Merck & Co. Inc.
Mylan N.V.
Natrol, LLC
Paratek Pharmaceuticals Inc.
Pfizer Inc.
Sanofi SA
Sumitomo Dainippon Pharma Co. Ltd.
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/insomnia-treatment-market
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/2029%eb%85%84%ea%b9%8c%ec%a7%80-%eb%86%80%eb%9d%bc%ec%9a%b4-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%a0-%eb%b3%b5%ed%95%a9-%ec%82%ac%eb%a3%8c-%ec%8b%9c%ec%9e%a5/168954/
https://monblogapple.com/2023/06/24/marche-des-fluides-dechappement-diesel-def-2023-recherche-sur-les-facteurs-de-conduite-2029/
https://perualdia.net/perspectivas-del-mercado-de-servicios-medicos-de-emergencia-2029-presenta-informacion-del-mercado-y-analisis-de-profundidad/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Treatment Market is thriving worldwide by 2029 here
News-ID: 3101981 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
